Fellowship · Kansas City, MO
Sponsored by Children's Mercy Hospital
Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study.
The Lancet. Haematology · 2025 · 93 citations · Jaszianne Tolbert
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing.
Nature biotechnology · 2026 · 29 citations · Erin Guest
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Blood cancer journal · 2024 · 93 citations · Jaszianne Tolbert
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 138 citations · Keith August
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 98 citations · Alan Gamis
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.
Haematologica · 2023 · 77 citations ·
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
JAMA oncology · 2022 · 81 citations · Alan Gamis
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 58 citations · Erin Guest